C2N, Unilabs sign global agreement on early Alzheimer's diagnostics

Alzheimers Phases Amyloid Social

C2N and Unilabs have signed a multiyear agreement that will provide access to C2N's Precivity blood tests for the early diagnosis of Alzheimer's disease to Unilabs' customers on an exclusive basis in the European Union (EU), including Norway and Switzerland, as well as the U.K., Peru, Saudi Arabia, and the United Arab Emirates.

The partnership will expand access to the Precivity portfolio of tests to over 75 countries, the companies said in a statement. The agreement will facilitate a planned technology transfer of C2N's proprietary portfolio of Alzheimer's blood biomarkers to a Unilabs testing network across the EU, the firms added.

Financial and other terms of the agreement were not disclosed.

C2N's PrecivityAD2 and PrecivityAD blood tests identify and measure proteins known to be associated with the presence of brain amyloid plaques and neurofibrillary tau tangles in the brain, which are hallmarks of Alzheimer's disease. Results from the Precivity tests, which are intended for use in patients age 55 and older with signs or symptoms of mild cognitive impairment or dementia, can be used along with other findings and test results to inform diagnosis, management, and treatment decisions.

Conventional testing may include amyloid PET scan or cerebrospinal fluid testing, which may be costly, invasive, or not widely accessible.

"Alzheimer's disease is on the rise, making it essential to innovate by offering less invasive and more accessible diagnostic procedures for patients," Dr. Rahul Chaudhary, head of innovation at Unilabs, said.

"All too often, diagnosing Alzheimer's has been painful, invasive, and expensive. This partnership will transform the diagnostic experience for patients with cognitive concerns while revolutionizing early diagnosis, and research efforts, and positively impacting long-term outcomes," Chauddhary said. 

The companies said that the Precivity blood tests will become available to Unilabs' customers over the coming months, depending on geographic region.

Page 1 of 41
Next Page